S-1·October 21, 2026 at 4:28 PM EDT·2 sources
Rezera files for IPO to back NLRP3 work in peripheral artery disease
Outlets covering it2 in 3 hours
Oct 21, 8 PMOct 21, 11 PM
What happened
- Rezera Inc. filed an S-1 registration statement with the SEC on October 21, 2026, to pursue an initial public offering.
Why it matters
The filing gives equity-capital-markets professionals an early indication of a potential healthcare IPO and creates a public disclosure record for investors and advisers.
Deal terms
ipo
Rezera Inc.
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- IPO registration (S-1)Oct 21Rezera Inc. files to go public
- First reported by Endpoints NewsOct 21Rezera files for IPO to back NLRP3 work in peripheral artery disease
Sources (2)
- SEC EDGAROct 21Rezera Inc. files to go public
- Endpoints NewsOct 21Rezera files for IPO to back NLRP3 work in peripheral artery disease
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.